Free Trial

Actinium Pharmaceuticals (ATNM) Earnings Date, Estimates & Call Transcripts

Actinium Pharmaceuticals logo
$1.21 -0.04 (-3.20%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.21 0.00 (0.00%)
As of 04/17/2025 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Actinium Pharmaceuticals Earnings Summary

Latest Q2 2024
Earnings Date
Aug. 5Estimated
Consensus EPS
(Aug. 5)
-$0.40
Actual EPS
(Aug. 5)
-$0.38 Beat By $0.02

Actinium Pharmaceuticals issued Q2 2024 earnings on August 5, 2024, reporting an EPS of -$0.38, which beat analysts' consensus estimates of -$0.40 by $0.02. With a trailing EPS of -$1.39, Actinium Pharmaceuticals' earnings are expected to grow next year, from ($1.41) to ($0.77) per share.

Q2 2024 Earnings Resources

Get Actinium Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Actinium Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ATNM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATNM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Actinium Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.26-$0.26-$0.26
Q2 20252-$0.33-$0.30-$0.32
Q3 20252-$0.35-$0.33-$0.34
Q4 20252-$0.39-$0.12-$0.26
FY 20258($1.33)($1.01)($1.17)

Actinium Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2024Q2 2024-$0.40-$0.38+$0.02-$0.38--
4/26/2024Q1 2024-$0.42-$0.31+$0.11-$0.31--
3/29/2024Q4 2023-$0.54-$0.33+$0.21-$0.33-$0.08M
11/2/2023Q3 2023--$0.49 -$0.49-$0.49--
8/14/2023Q2 2023-$0.50-$0.58 -$0.08-$0.58--
5/15/2023Q1 2023-$0.42-$0.43 -$0.01-$0.43--

Actinium Pharmaceuticals Earnings - Frequently Asked Questions

Actinium Pharmaceuticals (NYSE:ATNM) last announced its quarterly earning data on Monday, August 5, 2024. Learn more on ATNM's earnings history.

In the previous quarter, Actinium Pharmaceuticals (NYSE:ATNM) reported ($0.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.02. Learn more on analysts' earnings estimate vs. ATNM's actual earnings.

Actinium Pharmaceuticals (NYSE:ATNM) has a recorded annual revenue of $81,000.00.

Actinium Pharmaceuticals (NYSE:ATNM) has a recorded net income of -$48.82 million. ATNM has generated -$1.39 earnings per share over the last four quarters.

Actinium Pharmaceuticals's earnings are expected to grow from ($1.41) per share to ($0.77) per share in the next year.

More Earnings Resources from MarketBeat



This page (NYSE:ATNM) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners